Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment

Encouraging survival was observed in single arm and randomized phase 2 trials of patient-specific dendritic cell vaccines presenting autologous tumor antigens from autologous cancer cells that were derived from surgically resected metastases whose cells were self-renewing in vitro. Based on most adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillman, Robert Owen, Hsieh, Candace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966441/
https://www.ncbi.nlm.nih.gov/pubmed/31614482
http://dx.doi.org/10.3390/biomedicines7040080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966441/
https://www.ncbi.nlm.nih.gov/pubmed/31614482
http://dx.doi.org/10.3390/biomedicines7040080

Ejemplares similares